|
IT1190891B
(it)
|
1982-06-24 |
1988-02-24 |
Anic Spa |
Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
|
|
US5910304A
(en)
|
1982-12-13 |
1999-06-08 |
Texas A&M University System |
Low-dose oral administration of interferons
|
|
US5049386A
(en)
|
1985-01-07 |
1991-09-17 |
Syntex (U.S.A.) Inc. |
N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4946787A
(en)
|
1985-01-07 |
1990-08-07 |
Syntex (U.S.A.) Inc. |
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
CA1320905C
(en)
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
|
FI81498C
(fi)
|
1987-01-13 |
1990-11-12 |
Biocon Oy |
Kirurgiska material och instrument.
|
|
US5270171A
(en)
*
|
1987-03-06 |
1993-12-14 |
Boris Cercek |
Cancer-associated SCM-recognition factor, preparation and method of use
|
|
US5580561A
(en)
*
|
1987-03-06 |
1996-12-03 |
Cercek; Boris |
Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5693622A
(en)
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
US5676954A
(en)
|
1989-11-03 |
1997-10-14 |
Vanderbilt University |
Method of in vivo delivery of functioning foreign genes
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
US5981276A
(en)
|
1990-06-20 |
1999-11-09 |
Dana-Farber Cancer Institute |
Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
|
|
US5353535A
(en)
|
1990-11-05 |
1994-10-11 |
Plumly George W |
Floor type advertising apparatus
|
|
HUT71860A
(en)
|
1992-08-27 |
1996-02-28 |
Deakin Res Ltd |
Retro-, inverso-, and retro-inverso synthetic peptide analogues
|
|
DK0659073T3
(da)
|
1992-09-10 |
2002-03-11 |
Childrens Medical Center |
Bionedbrydelige polymermatrixer med vedvarerende afgivelse af lokalanæstetika
|
|
EP1024198A3
(en)
|
1992-12-03 |
2002-05-29 |
Genzyme Corporation |
Pseudo-adenoviral vectors for the gene therapy of haemophiliae
|
|
US5514653A
(en)
*
|
1994-09-09 |
1996-05-07 |
Washington University |
Method of blocking the SEC receptor
|
|
US5665557A
(en)
|
1994-11-14 |
1997-09-09 |
Systemix, Inc. |
Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
|
|
CA2234931C
(en)
|
1995-10-16 |
2010-01-19 |
Dana-Farber Cancer Institute |
Novel expression vectors and methods of use
|
|
US6036949A
(en)
|
1998-03-05 |
2000-03-14 |
Amarillo Biosciences, Inc. |
Treatment of fibromyalgia with low doses of interferon
|
|
DE69918090T2
(de)
|
1998-04-24 |
2005-06-16 |
University Of Florida, Gainesville |
Rekombinanter adeno-assoziierter viraler vektor, der alpha-1 antitrypsin kodiert, zur gentherapie
|
|
US20100210528A1
(en)
*
|
1999-03-05 |
2010-08-19 |
Leland Shapiro |
Compositions, methods and uses for inhibition and/or treatment of influenza infection
|
|
US20070003518A1
(en)
|
2002-04-19 |
2007-01-04 |
Atkinson Mark A |
Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases
|
|
US7850970B2
(en)
|
2003-08-26 |
2010-12-14 |
The Regents Of The University Of Colorado |
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
|
|
EP1703916A2
(en)
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
|
|
US20060141528A1
(en)
*
|
2004-05-21 |
2006-06-29 |
Aebersold Rudolf H |
Compositions and methods for quantification of serum glycoproteins
|
|
US8715649B2
(en)
|
2005-06-07 |
2014-05-06 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
|
|
WO2007070981A1
(en)
|
2005-12-23 |
2007-06-28 |
Vital Health Sciences Pty Ltd |
Compounds having cytokine modulating properties
|
|
EP1996215A2
(en)
|
2006-02-28 |
2008-12-03 |
Trustees Of Boston University |
Metabolic regulators and uses thereof
|
|
US20080008694A1
(en)
|
2006-07-05 |
2008-01-10 |
Elgebaly Salwa A |
Methods to prevent and treat diseases
|
|
US20090203602A1
(en)
*
|
2006-09-01 |
2009-08-13 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
|
US20100267052A1
(en)
|
2006-09-01 |
2010-10-21 |
American Type Culture Collection |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
ES2651268T3
(es)
|
2006-09-12 |
2018-01-25 |
Beth Israel Deaconess Medical Center, Inc. |
Composiciones que contienen alfa-1-antitripsina y métodos para su uso
|
|
DK2193142T3
(da)
|
2007-08-30 |
2015-04-20 |
Curedm Group Holdings Llc |
Præparater og fremgangsmåder til anvendelse af pro-øcellepeptider og analoger dertil
|
|
WO2009046015A2
(en)
|
2007-09-30 |
2009-04-09 |
University Of Florida Research Foundation, Inc. |
Combination therapies for treating type 1 diabetes
|
|
US7923253B2
(en)
*
|
2007-11-05 |
2011-04-12 |
Battelle Memorial Institute |
Method for identifying type I diabetes mellitus in humans
|
|
WO2011109768A2
(en)
|
2010-03-04 |
2011-09-09 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for modulating cardiac conditions
|
|
WO2011126882A2
(en)
*
|
2010-03-30 |
2011-10-13 |
American Type Culture Collection |
Therapeutic peptides and their derivatives and therapeutic uses thereof
|
|
US9005615B2
(en)
|
2010-05-06 |
2015-04-14 |
The Feinstein Institute For Medical Research |
Methods for treatment of inflammatory diseases
|
|
CA3077804C
(en)
|
2012-01-09 |
2023-07-25 |
Serpin Pharma, Llc |
Peptides and methods of using same
|
|
CA2896951A1
(en)
|
2012-01-10 |
2013-07-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
WO2014197524A2
(en)
|
2013-06-06 |
2014-12-11 |
Serpin Pharma, Llc |
Peptide therapy for treatment of alpha-1 antitrypsin deficiency and associated pathologies
|
|
KR20160146242A
(ko)
|
2015-06-12 |
2016-12-21 |
현대자동차주식회사 |
터보차저 엔진의 재순환 밸브 구동 장치 및 방법
|
|
WO2017040287A1
(en)
|
2015-08-28 |
2017-03-09 |
Serpin Pharma, Llc |
Methods for treatment of diseases
|